We are live on ! Find out more
DS

David Shaw D.E. Shaw & Co

AUM $210B
1-Year Est. Return 57.28%
 

David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.

This Fund
S&P 500
This Quarter Est. Return
-1.54%
1 Year Est. Return
+57.28%
3 Year Est. Return
+174.65%
5 Year Est. Return
+213.13%
10 Year Est. Return
+910.08%
AUM
$83.7B
AUM Growth
-$1.57B
Cap. Flow
-$3.66B
Cap. Flow %
-4.37%
Top 10 Hldgs %
8.74%
Holding
5,820
New
545
Increased
1,802
Reduced
1,597
Closed
678

Top Buys

Rank Stock Value
1
V icon
Visa
V
+$365M
2
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$307M
3
ADBE icon
Adobe
ADBE
+$250M
4
NVDA icon
NVIDIA
NVDA
+$242M
5
CRM icon
Salesforce
CRM
+$240M

Sector Composition

Rank Sector Weight
1 Technology 13.15%
2 Financials 9.51%
3 Healthcare 7.52%
4 Consumer Discretionary 6.79%
5 Communication Services 5.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DHI icon
5101
D.R. Horton
DHI
$41.5B
-9,571
Closed -$704K
DNA icon
5102
Ginkgo Bioworks
DNA
$460M
-285
Closed -$27K
DNLI icon
5103
Denali Therapeutics
DNLI
$3.84B
-86,113
Closed -$2.53M
DNUT icon
5104
Krispy Kreme
DNUT
$630M
-23,096
Closed -$314K
DNTH icon
5105
Dianthus Therapeutics
DNTH
$6.18B
-3,314
Closed -$64K
DOMO icon
5106
PUT
Domo
DOMO
$178M
-19,700
Closed -$548K
DRIO icon
5107
DarioHealth
DRIO
$70.2M
-1,196
Closed -$147K
DX
5108
Dynex Capital
DX
$3.23B
-98,094
Closed -$1.56M
DXLG icon
5109
Destination XL Group
DXLG
$34.3M
-36,146
Closed -$123K
EBF icon
5110
Ennis
EBF
$546M
-12,726
Closed -$257K
ECL icon
5111
PUT
Ecolab
ECL
$80.1B
-10,000
Closed -$1.54M
EDIT icon
5112
PUT
Editas Medicine
EDIT
$464M
-40,000
Closed -$473K
EEM icon
5113
iShares MSCI Emerging Markets ETF
EEM
$30.7B
-4,273,656
Closed -$171M
EG icon
5114
Everest Group
EG
$14.4B
-2,622
Closed -$735K
EGP icon
5115
EastGroup Properties
EGP
$10.8B
-3,404
Closed -$525K
EHC icon
5116
Encompass Health
EHC
$12B
-141,577
Closed -$6.31M
ELS icon
5117
Equity Lifestyle Properties
ELS
$12.7B
-11,671
Closed -$822K
EMB icon
5118
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$15B
-1,578,000
Closed -$135M
ENR icon
5119
Energizer
ENR
$1.47B
-119,238
Closed -$3.38M
EPC icon
5120
Edgewell Personal Care
EPC
$1.32B
-6,769
Closed -$234K
EQX icon
5121
Equinox Gold
EQX
$15.9B
-12,100
Closed -$54K
ESLT icon
5122
Elbit Systems
ESLT
$34.3B
-2,026
Closed -$465K
ETNB
5123
DELISTED
89bio
ETNB
-94,036
Closed -$303K
ETSY icon
5124
Etsy
ETSY
$7.83B
-129,332
Closed -$13.2M
EVLV icon
5125
Evolv Technologies
EVLV
$956M
-26,517
Closed -$71K

Similar funds

David Shaw's Q3 2022 Portfolio in Review

As of Q3 2022, David Shaw held 5,820 positions worth $83.7B, down 1.8% from $85.3B the previous quarter. Its ten largest holdings account for 8.7% of the portfolio.

David Shaw withdrew a net $3.66B in Q3 2022, closing 678 positions and reducing 1,597 holdings. Its most notable exit was iShares MSCI Emerging Markets ETF, an estimated $171M position sold in full.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Financials and Healthcare.

Against the trend, David Shaw opened a new position in Prologis worth $66.1M.

  • David Shaw's largest Q3 2022 buy was Prologis: 650,725 shares worth $66.1M.
  • David Shaw added most to Visa in Q3 2022, an estimated $365M increase.
  • David Shaw's biggest Q3 2022 reduction was PayPal, cutting an estimated $520M.
  • David Shaw fully exited iShares MSCI Emerging Markets ETF in Q3 2022, selling an estimated $171M.
  • David Shaw's ten largest holdings make up 8.7% of its $83.7B portfolio in Q3 2022.
  • David Shaw opened 545 new positions and closed 678 in Q3 2022.
  • David Shaw's portfolio value fell 1.8% quarter-over-quarter to $83.7B.

Based on D.E. Shaw & Co's 13F filing for Q3 2022, filed 14 Nov 2022.